Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 1116 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

 Table of Contents  
EDITORIAL
Year : 2012  |  Volume : 2  |  Issue : 1  |  Page : 1-2  

Biological clocks: The coming of age


Associate Professor, Physiology, Oman Medical College, Sohar, Sultanate of Oman

Date of Web Publication1-Jun-2012

Correspondence Address:
Chandrashekhar V Apte
Associate Professor, Physiology Course Director Human Function & Clinical Elective Program Coordinator Oman Medical College, Post Box 321, Postal Code 391, Sohar
Sultanate of Oman
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2229-516X.96788

Rights and Permissions

How to cite this article:
Apte CV. Biological clocks: The coming of age. Int J App Basic Med Res 2012;2:1-2

How to cite this URL:
Apte CV. Biological clocks: The coming of age. Int J App Basic Med Res [serial online] 2012 [cited 2020 Jan 26];2:1-2. Available from: http://www.ijabmr.org/text.asp?2012/2/1/1/96788

In the past several years, there has been a great deal of activity in the field of chronobiology and the impact of these developments on physiology and medicine is growing. [1],[2] The understanding about the cellular basis of various body rhythms is rapidly increasing. In view of this it is relevant to take a quick over-view of biological clocks.

Life evolved on earth slowly over a few billions of years. During this time, and before, the earth has been rotating around its own tilted axis and simultaneously revolving around the sun. Thus, it is no surprise that the periodic environmental consequences of the rotation (day and night), the tilt (changing day length) and of the revolution (seasons) should influence life-forms right from their primordial beginnings.

In the background of these periodic environmental factors, it is reasonable to believe that favorable inheritable changes would have persisted. The beneficial genetic mutations expected to be selected in primitive life-forms would surely include those that led to improved survival during potentially deleterious phases of the day-night cycle or during less drastic changes induced by the changing day-length and seasons. Due to the survival benefit, these inheritable characteristics became incorporated in advanced life-forms as they evolved from simpler forms. It is only now that the underlying intracellular mechanisms involved in circadian rhythms are being discovered in many types of human cells. [2] The currently accepted defining features of circadian rhythms include the property of persistence (also described as 'self-sustaining' or 'free-running'), aperiodicity of ~24 h, entrainability by external influences (typically light), and temperature independence.

Circadian, and possibly other, rhythms in living beings could not have escaped the notice of early man. However, in the present day, the first detailed, and academic, look at these phenomena is ascribed to De Marian in the sixteenth century. This Frenchman described leaf movements in plants exposed to day and night. He also showed that these persisted even when the plants were kept indoors, protected from the variations in light. [1]

The underlying feature of intracellular mechanisms that regulate circadian rhythms is the presence of oscillations. Feedback-based regulatory mechanisms can cause oscillations of the controlled variable if the feedback has a very high gain. It is easy to realize that any oscillatory mechanism with a periodicity of ~24 h can function as a circadian clock. In essence, these circadian clock regulators consist of genes whose transcription-translation cycles are subject to feedback from their own products. In reality, they may consist of several inter-linked regulatory genes and their products. Whatever the complexity, the underlying constant theme is an overall periodicity of ~24 h.

For over three decades the special position of the suprachiasmatic nuclei in circadian rhythms has been suspected. [3],[4] So where does it fit in the scheme of things now? It is now believed that these nuclei contain several cells with their own circadian rhythms but are entrained by light via the retinal specialized ganglion cells. Neural output from the suprachiasmatic nuclei is channeled into the pineal gland and into other hypothalamic regions. Influences from these areas, humoral or neural, may ultimately help in entraining or modulating the rhythmic function of peripheral biological clocks.

One of the earliest human rhythms to be recognized was that of adrenocortical secretions. [5],[6] Diurnal variations in ocular pressure and renal excretion have also been known for several years. [7] The existence of circadian rhythm in lung function meant that it was necessary that such recordings were made at the same time of the day for accuracy of comparison. [8],[9]

Trends in recent years are helping to bring forth new evidence suggesting an increasing role of abnormal circadian rhythms in tissues in the pathogenesis of several types of diseases. This has been implicated in the development of obesity. [10] In a related study, it has been shown that there is circadian rhythmicity in leptin expression and also in the number of its receptors on visceral fat cells. [11] There may also be gender-specific differences in clock genes of adipose tissue. [12] This suggests that the future may show novel developments in the understanding of how obesity develops and new ways of dealing with this problem.

The cellular elements of blood also experience circadian rhythms. The expression of thrombopoietin is regulated by a cellular mechanism. [13] Besides this it has been shown that an intrinsic cellular circadian oscillator regulates the CD4+ T cell immnune responses. [14]

A recent meta-analysis has shown that blood pressure (BP) is lowered better by antihypertensive given at bedtime than in the morning. However, this analysis failed to find conclusive evidence of reduced cardiovascular events despite the better BP control. [15] The possible link between cardiovascular events and circadian variations of blood pressure appears now to be widely accepted.

The field of chronotherapeutics that aims at tuning the administration of drugs is also expanding rapidly. It is now being recognized that maintaining a steady blood level of a drug may not always be desirable and it may be better to be in step with the biological clocks. This has beneficial effects in terms of bioavailability, drug metabolism, and pharmacodynamics. Drugs where these ideas have been established include bronchodilators, glucocorticoids, and nonsteroidal anti-inflammatory drugs. [16] Introduced recently, Bromocriptine, an oral antidiabetic drug for use as adjunct to diet and exercise in type-2 diabetics, is claimed to work by correcting the disrupted circadian rhythm. [17]

In view of these exciting recent developments, one can expect that in the near future there will be an even greater understanding of biological clocks. This should help in the development of many more clinical and therapeutic strategies in areas that were thought to be uninfluenced by fundamental and inherent oscillatory phenomenon that have their origin in the way that primordial life developed.

 
   References Top

1.Isaac E. Circadian rhythms in a nutshell. Physiol Genomics 2000;3:59-69.   Back to cited text no. 1
    
2.Lowrey PL, Takahashi JS. Genetics of circadian rhythms in mammalian model organisms. Adv Genetics 2011;74:175-223.   Back to cited text no. 2
    
3.Nishino H, Kiyomi K, Brooks CM. The role of suprachiasmatic nuclei of the hypothalamus in the production of circadian rhythm. Brain Res 1976;112:45-59.   Back to cited text no. 3
    
4.Stetson MH, Watson-Whitmyre M. Nucleus suprachiasmaticus: the biological clock in the hamster? Science 1976;191:197-9.   Back to cited text no. 4
    
5.Liddle GW. An analysis of circadian rhythms in human adrenocortical secretory activity. Trans Am Clin Climatol Assoc 1966;77:151-60.   Back to cited text no. 5
    
6.Pincus G. A Diurnal Rhythmn in the Excretion of Urinary Ketosteroids by Young Men. J ClinEndocr 1943;3:195.   Back to cited text no. 6
    
7.Lobban MC. Daily rhythms of renal excretion in Arctic-dwelling Indians and Eskimos. Q J Exp Physiol Cogn Med Sci 1967;52:401-10.   Back to cited text no. 7
    
8.Carey GC, Dawson TA, Merrett JD. Addendum to Daily changes in Ventilatory Capacity in Smokers and Non-smokers. Br J Prev Soc Med 1968;22:59.   Back to cited text no. 8
    
9.Guberan E, Williams MK, Walford J, Smith MM. Circadian variation of F.E.V. in shift workers. Br J Ind Med 1969;26:121-5.   Back to cited text no. 9
    
10.Cheung WW, Mao P. Recent advances in obesity: genetics and beyond. ISRN Endocrinol2012;2012:536905.   Back to cited text no. 10
    
11.Gómez Abellán P, Gómez Santos C, Madrid JA, Milagro FI, Campion J, Martínez JA, et al. Site-specific circadian expression of leptin and its receptor in human adipose tissue. Nutr Hosp 2011;26:1394-401.   Back to cited text no. 11
    
12.Zanquetta MM, Correa-Giannella ML, Giannella-Neto D, Alonso PA, Guimarães LM, Meyer A, et al. Expression of clock genes in human subcutaneous and visceral adipose tissues. Chronobiol Int 2012;29:252-60.   Back to cited text no. 12
    
13.Tracey CJ, Pan X, Catterson JH, Harmar AJ, Hussain MM, Hartley PS. Diurnal expression of the thrombopoietin gene is regulated by CLOCK. J ThrombHaemost 2012;10:662-9.   Back to cited text no. 13
    
14.Bollinger T, Leutz A, Leliavski A, Skrum L, Kovac J, Bonacina L, et al. Circadian clocks in mouse and human CD4+ T cells. PLoS One 2011;6:e29801.   Back to cited text no. 14
    
15.Zhao P, Xu P, Wan C, Wang Z. Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database Syst Rev 2011;10:CD004184.   Back to cited text no. 15
    
16.Lévi F, Okyar A. Circadian clocks and drug delivery systems: Impact and opportunities in chronotherapeutics. Expert Opin Drug Deliv 2011;8:1535-41.   Back to cited text no. 16
    
17.ahajan R. Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes. Indian J Pharmacol 2009;41:197-8.  Back to cited text no. 17
    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed1904    
    Printed223    
    Emailed0    
    PDF Downloaded415    
    Comments [Add]    

Recommend this journal